Variable | Total (n=135) | Robotic surgery (n=77) | Laparotomy (n=58) |
Age, median (range), year | 63 (40–89) | 64 (40–89) | 63 (48–83) |
Follow-up, median (range), year | 4.6 (1.1–8.8) | 5.9 (1.1–8.8) | 4.2 (1.9–8.8) |
Grade, n (%) | |||
1 | 37 (27.4) | 27 (35.1) | 10 (17.2) |
2 | 88 (65.2) | 45 (58.4) | 43 (74.1) |
3 | 10 (7.4) | 5 (6.5) | 5 (8.6) |
Depth of myometrial invasion, n (%) | |||
<50% | 62 (45.9) | 33 (42.9) | 29 (50.0) |
>50% | 73 (54.1) | 44 (57.1) | 29 (50.0) |
LVSI, n (%) | 31 (23.0) | 19 (24.7) | 12 (20.7) |
Adjuvant RT, n (%) | |||
EBRT | 28 (20.7) | 15 (19.5) | 13 (22.4) |
VBT | 107 (79.3) | 62 (80.5) | 45 (77.6) |
Time interval between surgery and adjuvant RT, median (range), days | 77 (22–187) | 85 (46–187) | 66 (22–125) |
LN dissection, n (%) | 107 (79.3) | 66 (85.7) | 41 (70.7) |
Number of LN sampled, mean±SD | 9.1±5.0 | 8.8±4.9 | 9.6±5.1 |
HIR patients, number (%) | 61 (45.2) | 36 (46.8) | 25 (43.1) |
Differences between the two groups were not statistically significant across all variables (p=ns). (If two of the three criteria are met: age 60 years or older, >50% myometrial invasion, grade 3).
EBRT, external-beam radiotherapy; HIR, high-intermediate risk; LN, lymph node; LVSI, lymphovascular space invasion; RT, radiotherapy; VBT, vaginal brachytherapy.